Inovio Pharmaceuticals Ownership | Who Owns Inovio Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Inovio Pharmaceuticals Ownership Summary


Inovio Pharmaceuticals is owned by 47.43% institutional investors, 0.61% insiders, and 51.96% retail investors. Ifp advisors is the largest institutional shareholder, holding 0% of INO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.14% of its assets in Inovio Pharmaceuticals shares.

INO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockInovio Pharmaceuticals47.43%0.61%51.96%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ifp advisors---
Prime capital investment advisors---
Sachetta---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ifp advisors---
Prime capital investment advisors---
Sachetta---

Top Buyers

HolderShares% AssetsChange
Sachetta---3.00
Ifp advisors---175.00
Prime capital investment advisors---10.17K

Top Sellers

HolderShares% AssetsChange
Prime capital investment advisors---10.17K
Ifp advisors---175.00
Sachetta---3.00

Sold Out

HolderChange
Sachetta-3.00
Ifp advisors-175.00
Prime capital investment advisors-10.17K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241063.92%13,346,63655.81%475.12%5826.09%15-28.57%
Sep 30, 2024102-8,566,0456.31%303.47%46-13.21%21-
Jun 30, 202410210.87%8,057,46098.11%299.72%5360.61%21-62.50%
Mar 31, 20243-97.32%10,350-99.98%-0.01%1-97.44%2-93.55%
Dec 31, 2023112-11.81%49,839,946-10.29%184.20%39-9.30%31-24.39%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.13M3.14%-
iShares Russell 2000 ETF896.84K2.45%-7.75K
Vanguard US Total Market Shares ETF818.82K2.23%-
Vanguard Institutional Extnd Mkt Idx Tr366.50K1.02%-
iShares Russell 2000 Value ETF331.13K0.90%-
Fidelity Small Cap Index267.89K0.73%-5.02K
Vanguard Strategic Equity Inv250.14K0.69%-
State St Russell Sm/Mid Cp® Indx NL Cl C150.74K0.42%-
State St Russell Sm/Mid Cp® Indx SL Cl I150.74K0.41%-
Fidelity Extended Market Index141.73K0.39%67.67K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 05, 2023Zoth Lota S.-Sell$3.19K
Mar 13, 2023Weiner David B.-Sell$6.71K
Feb 27, 2023Weiner David B.-Sell$14.94K
Aug 11, 2022Weiner David B. Sell$31.59K
Jul 20, 2022BENITO SIMON X Sell$4.50K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q4--
2024 Q2--
2024 Q1--
2023 Q2-1

INO Ownership FAQ


Who Owns Inovio Pharmaceuticals?

Inovio Pharmaceuticals shareholders are primarily institutional investors at 47.43%, followed by 0.61% insiders and 51.96% retail investors. The average institutional ownership in Inovio Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which Inovio Pharmaceuticals falls below.

Does Blackrock own Inovio Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Inovio Pharmaceuticals.

Who is Inovio Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Ifp advisors is Inovio Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Inovio Pharmaceuticals shares, valued at 0$.

Who is the top mutual fund holder of Inovio Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Inovio Pharmaceuticals shares, with 3.14% of its total shares outstanding invested in 1.13M Inovio Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools